Idiopathic Parkinson's Disease

2

Review clinical trials related to Idiopathic Parkinson's Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease

This clinical trial is designed to test the safety and tolerability of the study intervention, RNDP-001, which will be implanted into the brain of study participants during a surgical procedure.

Participants needed: 12
Trial details
Phase: Phase 1, Phase 2Age: 45-75Biological sex: AllType: InterventionalSponsor: Kenai TherapeuticsUpdated: Jan 23, 2026Locations: 3
Eligibility criteria

Diagnosis of idiopathic Parkinson's disease consistent with the Movement Disorde... [+2]

Known Parkinson's disease gene mutation or variant [+4]

Status: Not yet recruiting

Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease

Primary Objective: To assess the safety profile of autologous MitoCell administered to subjects with idiopathic Parkinson's disease (PD) Secondary Objective: To explore the efficacy and safety of MitoCell given as the recommended dose by stereotactic intrastriatal implantation

Participants needed: 9
Trial details
Phase: Phase 1Age: 45-70Biological sex: AllType: InterventionalSponsor: Taiwan Mitochondrion Applied Technology Co., Ltd.Updated: Nov 21, 2024
Eligibility criteria

Provision of signed and dated informed consent form [+9]

Atypical or secondary Parkinsonism [+34]